Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
Researchers say a generic version could be made for just $25 per person a year.
Capitalism kills.
Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
Researchers say a generic version could be made for just $25 per person a year.
Capitalism kills.
@graf @sun @luckytran @Leyonhjelm @lispi314 I was nodding along reading this exchange earlier, so I was shocked to just hear a piece on the radio about getting more women on PREP that said thirty percent of HIV diagnoses in the UK are heterosexual women.
Then the interviewer asked if any groups were particularly prevalent: black African, black Caribbean, immigrants, “sex workers” and just generally (oh, the euphemisms) “women who have less agency around whether they have sex”.
GNU social JP is a social network, courtesy of GNU social JP管理人. It runs on GNU social, version 2.0.2-dev, available under the GNU Affero General Public License.
All GNU social JP content and data are available under the Creative Commons Attribution 3.0 license.